Laparoscopic assisted distal gastrectomy for early gastric cancer: Five years' experience.

Advantages of totally laparoscopic distal gastrectomy over laparoscopically assisted distal gastrectomy for gastric cancer. Surg Endosc (2009) 2.41

Laparoscopic-assisted distal gastrectomy versus open distal gastrectomy for advanced gastric cancer. Surg Endosc (2008) 2.26

Totally laparoscopic gastrectomy with various types of intracorporeal anastomosis using laparoscopic linear staplers: preliminary experience. Surg Endosc (2008) 1.99

Laparoscopically assisted total gastrectomy with lymph node dissection for upper and middle gastric cancer. Surg Endosc (2008) 1.82

Safety and feasibility of laparoscopy-assisted distal gastrectomy with suprapancreatic nodal dissection for clinical stage I gastric cancer: a multicenter phase II trial (JCOG 0703). Gastric Cancer (2010) 1.81

Long-term quality of life after laparoscopy-assisted distal gastrectomy for gastric cancer. Surg Endosc (2007) 1.73

General complications following laparoscopic-assisted gastrectomy and analysis of techniques to manage them. Surg Endosc (2009) 1.66

Predictive factors for surgical complications of laparoscopy-assisted distal gastrectomy for gastric cancer. Surg Endosc (2008) 1.64

Laparoscopic gastrectomy with lymph node dissection for gastric cancer. Gastric Cancer (2006) 1.35

Comparison of outcomes for laparoscopically assisted and open radical distal gastrectomy with lymphadenectomy for advanced gastric cancer. Surg Endosc (2011) 1.15

SAGES TAVAC safety and effectiveness analysis: da Vinci ® Surgical System (Intuitive Surgical, Sunnyvale, CA). Surg Endosc (2015) 1.13

Comparison of long-term prognosis of laparoscopy-assisted gastrectomy and conventional open gastrectomy with special reference to D2 lymph node dissection. Surg Endosc (2012) 1.12

Survival and surgical outcomes after laparoscopy-assisted total gastrectomy for gastric cancer: case-control study. Surg Endosc (2012) 1.12

Meta-analysis of short-term outcomes after laparoscopy-assisted distal gastrectomy. World J Gastroenterol (2006) 1.12

Laparoscopy-assisted versus open gastrectomy with D2 lymph node dissection for advanced gastric cancer: a meta-analysis. Int J Clin Exp Med (2014) 1.06

Total and subtotal laparoscopic gastrectomy for adenocarcinoma. Surg Endosc (2006) 1.05

Complications with laparoscopically assisted gastrectomy: multivariate analysis of 300 consecutive cases. Surg Endosc (2008) 1.04

Case-matched comparison of laparoscopy-assisted and open distal gastrectomy for gastric cancer. World J Gastroenterol (2013) 1.03

Laparoscopy-assisted gastrectomy with D2 lymph node dissection for advanced gastric cancer without serosa invasion: a matched cohort study from South China. World J Surg Oncol (2013) 1.03

Pilot series of robot-assisted laparoscopic subtotal gastrectomy with extended lymphadenectomy for gastric cancer. Surg Endosc (2007) 1.00

Clinical characteristics and outcomes for gastric cancer patients aged 18-30 years. Gastric Cancer (2014) 1.00

Laparoscopic versus open total gastrectomy for gastric cancer: an updated meta-analysis. PLoS One (2014) 0.99

Laparoscopic versus open total gastrectomy with D2 dissection for gastric cancer: a meta-analysis. J Cancer Res Clin Oncol (2013) 0.98

Esophagojejunostomy through minilaparotomy after laparoscopic total gastrectomy. Gastric Cancer (2007) 0.97

Laparoscopy-assisted distal gastrectomy versus open distal gastrectomy. A prospective randomized single-blind study. World J Surg (2013) 0.93

Laparoscopic vs open D2 gastrectomy for locally advanced gastric cancer: a meta-analysis. World J Gastroenterol (2014) 0.93

The benefits of standardizing the operative procedure for the assistant in laparoscopy-assisted gastrectomy for gastric cancer. Langenbecks Arch Surg (2008) 0.92

Preoperative assessment of perigastric vascular anatomy by multidetector computed tomography angiogram for laparoscopy-assisted gastrectomy. Langenbecks Arch Surg (2012) 0.92

Comparison of laparoscopically assisted and open radical distal gastrectomy with extended lymphadenectomy for gastric cancer management. Surg Endosc (2006) 0.91

Quality of life beyond the early postoperative period after laparoscopy-assisted distal gastrectomy: the level of patient expectation as the essence of quality of life. Gastric Cancer (2011) 0.86

Mechanical-stapled versus hand-sutured anastomoses in billroth-I reconstruction with distal gastrectomy. Surg Today (2007) 0.86

Comparison of short-term outcomes and acute inflammatory response between laparoscopy-assisted and totally laparoscopic distal gastrectomy for early gastric cancer. Ann Surg Treat Res (2015) 0.85

Potentially fatal complications for elderly patients after laparoscopy-assisted distal gastrectomy. Gastric Cancer (2013) 0.84

Laparoscopy Assisted versus Open Distal Gastrectomy with D2 Lymph Node Dissection for Advanced Gastric Cancer: Design and Rationale of a Phase II Randomized Controlled Multicenter Trial (COACT 1001). J Gastric Cancer (2013) 0.83

Evaluation of the safety and efficacy of esophagojejunostomy after totally laparoscopic total gastrectomy using a trans-orally inserted anvil: a single-center comparative study. Surg Endosc (2014) 0.82

The impact of abdominal shape index of patients on laparoscopy-assisted distal gastrectomy for early gastric cancer. Langenbecks Arch Surg (2011) 0.82

Safety and efficacy of laparoscopy-assisted gastrectomy for advanced gastric cancer in the elderly. Int J Clin Exp Med (2014) 0.82

Effects of HIF-1alpha on human gastric cancer cell apoptosis at different CO(2) pressures. Clin Exp Med (2008) 0.81

Laparoscopic subtotal gastrectomy for gastric cancer. JSLS (2009) 0.80

Quality control and educational value of laparoscopy-assisted gastrectomy in a high-volume center. Surg Endosc (2008) 0.79

Virally-directed fluorescent imaging (VFI) can facilitate endoscopic staging. Surg Endosc (2006) 0.78

Delta-Shaped Gastroduodenostomy in Fully Laparoscopic Distal Gastrectomy: A Retrospective Study. Medicine (Baltimore) (2015) 0.77

Total laparoscopic resection for advanced gastric cancer is safe and feasible in the Western population. Surg Endosc (2015) 0.77

Comparison of laparoscopy-assisted and open radical gastrectomy for advanced gastric cancer: A retrospective study in a single minimally invasive surgery center. Medicine (Baltimore) (2016) 0.77

N staging: the role of the pathologist. Transl Gastroenterol Hepatol (2017) 0.75

Totally laparoscopic D2 radical distal gastrectomy using Billroth II anastomosis: A case report. Oncol Lett (2016) 0.75

Production of intraperitoneal interleukin-6 following open or laparoscopic assisted distal gastrectomy. Int Surg (2014) 0.75

Comparison of early-term effects between totally laparoscopic distal gastrectomy with delta-shaped anastomosis and conventional laparoscopic-assisted distal gastrectomy: a retrospective study. Int J Clin Exp Med (2015) 0.75

Re: "laparoscopic assisted distal gastrectomy for early gastric cancer: five years' experience". Surgery (2005) 0.75

Do preoperative enlarged lymph nodes affect the oncologic outcome of laparoscopic radical gastrectomy for gastric cancer? Oncotarget (2016) 0.75

A comparison of surgical procedures and postoperative cares for minimally invasive laparoscopic gastrectomy and open gastrectomy in gastric cancer. Int J Clin Exp Med (2015) 0.75

Comparison of three different minimally invasive procedures of distal gastrectomy for Nonoverweight patients with T1N0-1 gastric cancer. Int Surg (2013) 0.75

Laparoscopic gastrectomy versus open gastrectomy for elderly patients with gastric cancer: a systematic review and meta-analysis. World J Surg Oncol (2016) 0.75

Laparoscopy-assisted subtotal gastrectomy under thoracic epidural-general anesthesia leading to the effects on postoperative micturition. Surg Endosc (2008) 0.75

Minimally Invasive Gastric Surgery. Adv Surg (2017) 0.75

Laparoscopy-assisted distal gastrectomy with D1+beta compared with D1+alpha lymph node dissection. Surg Endosc (2007) 0.75

Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications. Cancer Res (2004) 7.76

Analysis of epidermal growth factor receptor gene mutation in patients with non-small cell lung cancer and acquired resistance to gefitinib. Clin Cancer Res (2006) 4.62

The diagnosis and treatment of adult intussusception. J Clin Gastroenterol (2003) 3.06

Irinotecan plus S-1 (IRIS) versus fluorouracil and folinic acid plus irinotecan (FOLFIRI) as second-line chemotherapy for metastatic colorectal cancer: a randomised phase 2/3 non-inferiority study (FIRIS study). Lancet Oncol (2010) 2.73

Inhibition of autophagy by 3-MA enhances the effect of 5-FU-induced apoptosis in colon cancer cells. Ann Surg Oncol (2008) 2.56

Inhibition of autophagy augments 5-fluorouracil chemotherapy in human colon cancer in vitro and in vivo model. Eur J Cancer (2010) 1.93

Prognostic model of pulmonary adenocarcinoma by expression profiling of eight genes as determined by quantitative real-time reverse transcriptase polymerase chain reaction. J Clin Oncol (2004) 1.89

IL-15 regulates CD8+ T cell contraction during primary infection. J Immunol (2006) 1.88

Evaluation of 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography for gastric cancer. World J Surg (2004) 1.87

Prognostic implication of EGFR, KRAS, and TP53 gene mutations in a large cohort of Japanese patients with surgically treated lung adenocarcinoma. J Thorac Oncol (2009) 1.85

Thoracic and cardiovascular surgery in Japan during 2011: Annual report by The Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg (2013) 1.84

Laparoscopically assisted total gastrectomy with lymph node dissection for upper and middle gastric cancer. Surg Endosc (2008) 1.82

Activation of MET by gene amplification or by splice mutations deleting the juxtamembrane domain in primary resected lung cancers. J Thorac Oncol (2009) 1.81

Gum chewing enhances early recovery from postoperative ileus after laparoscopic colectomy. J Am Coll Surg (2002) 1.77

c-myc is a downstream target of the Smad pathway. J Biol Chem (2001) 1.74

EphA2 overexpression correlates with poor prognosis in esophageal squamous cell carcinoma. Int J Cancer (2003) 1.68

Thoracic and cardiovascular surgery in Japan during 2012 : annual report by The Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg (2014) 1.65

Laparoscopy-assisted proximal gastrectomy with gastric tube reconstruction for early gastric cancer. Surg Endosc (2010) 1.65

The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma. Cancer (2005) 1.64

Biological and genetic characteristics of tumor-initiating cells in colon cancer. Ann Surg Oncol (2007) 1.62

Should patients over 85 years old be operated on for colorectal cancer? J Clin Gastroenterol (2004) 1.52

Overexpression of IL-15 in vivo increases antigen-driven memory CD8+ T cells following a microbe exposure. J Immunol (2002) 1.51

PTEN and PIK3CA expression is associated with prolonged survival after gefitinib treatment in EGFR-mutated lung cancer patients. J Thorac Oncol (2006) 1.50

TP53 mutations in nonsmall cell lung cancer. J Biomed Biotechnol (2011) 1.46

Adenovirus-mediated overexpression of the activin betaC subunit accelerates liver regeneration in partially hepatectomized rats. J Hepatol (2005) 1.45

Mechanisms of resistance to EGFR TKIs and development of a new generation of drugs in non-small-cell lung cancer. J Biomed Biotechnol (2011) 1.42

Impact of gastropyloric motor activity on the genesis of reflux esophagitis after an esophagectomy with gastric tube reconstruction. Ann Thorac Surg (2013) 1.42

Gastrointestinal recovery and outcome after laparoscopy-assisted versus conventional open distal gastrectomy for early gastric cancer. World J Surg (2002) 1.41

Is an elderly recipient a risk for living donor adult liver transplantation? Hepatogastroenterology (2008) 1.38

p53-Altered FBXW7 expression determines poor prognosis in gastric cancer cases. Cancer Res (2009) 1.37

Thoracic and cardiovascular surgery in Japan during 2009: annual report by the Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg (2011) 1.35

MicroRNA miR-125b is a prognostic marker in human colorectal cancer. Int J Oncol (2011) 1.34

Expression of cancer/testis (CT) antigens in lung cancer. Lung Cancer (2003) 1.31

High-level expression of the Smad ubiquitin ligase Smurf2 correlates with poor prognosis in patients with esophageal squamous cell carcinoma. Cancer Res (2002) 1.30

Plastin3 is a novel marker for circulating tumor cells undergoing the epithelial-mesenchymal transition and is associated with colorectal cancer prognosis. Cancer Res (2013) 1.29

Thoracoscopic treatment of Bochdalek hernia in the adult: report of a case. Ann Thorac Cardiovasc Surg (2002) 1.29

Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma. Cancer (2002) 1.28

MiR-150 is associated with poor prognosis in esophageal squamous cell carcinoma via targeting the EMT inducer ZEB1. Cancer Sci (2012) 1.27

Distal pancreatectomy: is staple closure beneficial? ANZ J Surg (2003) 1.25

Laparoscopic appendectomy for appendiceal endometriosis presenting as acute appendicitis: report of a case. Surg Today (2007) 1.25

Selenium enrichment of broccoli sprout extract increases chemosensitivity and apoptosis of LNCaP prostate cancer cells. BMC Cancer (2009) 1.25

Thoracic and cardiovascular surgery in Japan during 2008: annual report by The Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg (2010) 1.24

Prognostic and predictive implications of HER2/ERBB2/neu gene mutations in lung cancers. Lung Cancer (2011) 1.23

18F-fluorodeoxyglucose positron emission tomography: useful technique for predicting malignant potential of gastrointestinal stromal tumors. World J Surg (2005) 1.22

Transient gene silencing of galectin-3 suppresses pancreatic cancer cell migration and invasion through degradation of β-catenin. Int J Cancer (2011) 1.21

Preoperative diagnosis of lymph node metastases of colorectal cancer by FDG-PET/CT. Jpn J Clin Oncol (2008) 1.18

Reduced expression of transforming growth factor-beta receptors is an unfavorable prognostic factor in human esophageal squamous cell carcinoma. Int J Cancer (2003) 1.17

Expression of EphA2 and E-cadherin in colorectal cancer: correlation with cancer metastasis. Oncol Rep (2004) 1.16

Schwannoma of the breast: report of a case. Surg Today (2005) 1.16

Safe and effective sedation in endoscopic submucosal dissection for early gastric cancer: a randomized comparison between propofol continuous infusion and intermittent midazolam injection. J Gastroenterol (2010) 1.15

Implication of galectin-3 in Wnt signaling. Cancer Res (2005) 1.12

Prognostic significance of EpCAM expression in human esophageal cancer. Int J Oncol (2007) 1.11

Primary squamous cell carcinoma of the stomach: a case report with immunohistochemical and molecular biologic studies. Hepatogastroenterology (2005) 1.10

Rationale for antiangiogenic cancer therapy with vaccination using epitope peptides derived from human vascular endothelial growth factor receptor 2. Cancer Res (2005) 1.10

Predictive and prognostic role of activated mammalian target of rapamycin in cervical cancer treated with cisplatin-based neoadjuvant chemotherapy. Oncol Rep (2006) 1.09

Hepatocellular carcinoma producing a granulocyte colony-stimulating factor: report of a resected case with a literature review. Liver Int (2007) 1.07

Expression of an activated mammalian target of rapamycin in adenocarcinoma of the cervix: A potential biomarker and molecular target therapy. Mol Carcinog (2008) 1.07

The clinical application of (18)F-fluorodeoxyglucose positron emission tomography to predict survival in patients with operable esophageal cancer. Cancer (2009) 1.07

Thoracic and cardiovascular surgery in Japan during 2007. Annual report by the Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg (2009) 1.07

CD24 expression is a novel prognostic factor in esophageal squamous cell carcinoma. Ann Surg Oncol (2008) 1.06

Autocrine motility factor signaling enhances pancreatic cancer metastasis. Clin Cancer Res (2004) 1.06

Comparison between whole-body positron emission tomography and bone scintigraphy in evaluating bony metastases of esophageal carcinomas. Anticancer Res (2005) 1.06

Nuclear beta-catenin expression at the invasive front and in the vessels predicts liver metastasis in colorectal carcinoma. Anticancer Res (2008) 1.05

Identification of overexpressed genes in hepatocellular carcinoma, with special reference to ubiquitin-conjugating enzyme E2C gene expression. Int J Cancer (2007) 1.05

Esophageal granular cell tumor covered by intramucosal squamous cell carcinoma: report of a case. Surg Today (2008) 1.05

Gastric schwannomas show an obviously increased fluorodeoxyglucose uptake in positron emission tomography: report of two cases. Surg Today (2011) 1.05

Nuclear karyopherin-α2 expression in primary lesions and metastatic lymph nodes was associated with poor prognosis and progression in gastric cancer. Carcinogenesis (2013) 1.05

Molecular processes of chromosome 9p21 deletions in human cancers. Oncogene (2003) 1.05

Increased expression of c-Ski as a co-repressor in transforming growth factor-beta signaling correlates with progression of esophageal squamous cell carcinoma. Int J Cancer (2004) 1.04

Significance of karyopherin-{alpha} 2 (KPNA2) expression in esophageal squamous cell carcinoma. Anticancer Res (2010) 1.04

Predictive value of blood flow in the gastric tube in anastomotic insufficiency after thoracic esophagectomy. World J Surg (2002) 1.04

Clinical and prognostic significance of RhoA and RhoC gene expression in esophageal squamous cell carcinoma. Ann Surg Oncol (2007) 1.03

alpha1-acid glycoprotein fucosylation as a marker of carcinoma progression and prognosis. Cancer (2004) 1.03

Clinicopathological significance of stanniocalcin 2 gene expression in colorectal cancer. Int J Cancer (2009) 1.02

Laparoscopy-assisted gastrectomy for early gastric cancer in young and elderly patients. World J Surg (2005) 1.02

Stathmin1 regulates p27 expression, proliferation and drug resistance, resulting in poor clinical prognosis in cholangiocarcinoma. Cancer Sci (2014) 1.01

Thickness of subcutaneous fat as a strong risk factor for wound infections in elective colorectal surgery: impact of prediction using preoperative CT. Dig Surg (2010) 1.01

The role of P-glycoprotein in intestinal tumorigenesis: disruption of mdr1a suppresses polyp formation in Apc(Min/+) mice. Carcinogenesis (2003) 0.99

Prolyl isomerase Pin1 expression predicts prognosis in patients with esophageal squamous cell carcinoma and correlates with cyclinD1 expression. Int J Oncol (2006) 0.99

Nonendothelial mesenchymal cell-derived MCP-1 is required for FGF-2-mediated therapeutic neovascularization: critical role of the inflammatory/arteriogenic pathway. Arterioscler Thromb Vasc Biol (2006) 0.99

Enforced expression of Bcl-2 partially restores cell numbers but not functions of TCRgammadelta intestinal intraepithelial T lymphocytes in IL-15-deficient mice. J Immunol (2007) 0.99